Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001496 · ClinicalTrials.gov registry record
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
A clinical trial of Breast Neoplasm and Hereditary Neoplastic Syndrome, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT00001496 is a study of Breast Neoplasm and Hereditary Neoplastic Syndrome that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 50 participants, below the 161-participant average among 26 other Breast Neoplasm trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00001496, a study of Breast Neoplasm and Hereditary Neoplastic Syndrome, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Women who are at high risk for breast cancer, either because of linkage to high risk breast and ovarian cancer families, or because of a carcinoma in the opposite breast, will be studied. Women will have a physical examination and mammography to ensure that no breast abnormalities are present. Eligible women will undergo biopsy of the breast to obtain normal breast tissue. Short-term cell cultures will be established from this tissue and early passages of the short-term cell lines will be stored. A bank of high risk normal mammary epithelial cells will be established. To further characterize the mammary epithelial cells in this population of women, cell cultures will subsequently be analyzed for their growth and metabolic properties, sensitivity to chemopreventive agents, steroid receptor characteristics, oncogene expression and regulation, and genetic changes.
Conditions Studied
Study Locations (1)
Maryland
- National Cancer Institute (NCI) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 1996-01 |
| Est. Completion | 2001-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001496
The ClinicalTrials.gov registry entry for NCT00001496 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 161-participant average among 26 other Breast Neoplasm trials with a reported enrollment target (69% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Neoplasm appearing as the primary indexed condition, and to 0 interventions.
NCT00001496 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00001496 about?
NCT00001496 is a clinical study titled "Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer". Women who are at high risk for breast cancer, either because of linkage to high risk breast and ovarian cancer families, or because of a carcinoma in the opposite breast, will be studied. Women will have a physical examination and mammography to ensure that no breast abnormalities are present. Eligi...
What is the current status of trial NCT00001496?
This trial is currently completed. The enrollment target is 50 participants. The study started on 1996-01. Estimated completion is 2001-11.
What conditions does trial NCT00001496 study?
This clinical trial studies the following conditions: Breast Neoplasm, Hereditary Neoplastic Syndrome.
Who is sponsoring clinical trial NCT00001496?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001496 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surviving Daily Life
RECRUITING
-
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
RECRUITING · NA
-
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
RECRUITING · Phase 2
-
Cryoablation vs Lumpectomy in T1 Breast Cancers
RECRUITING · NA
-
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
RECRUITING · NA
-
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.